Award
National Institutes of Health 11325889
Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis
Recipient
RANDALL J BATEMAN
Award Amount
$6,188,773.00
Ceiling
$6,188,773.00
Awarded
May 19, 2026
Identifier
11325889
A research project funded by NIH to develop blood biomarkers for early diagnosis and treatment of Alzheimer's disease, involving clinical and biomarker studies.
Description
This project aims to develop and validate blood-based biomarkers for Alzheimer's disease to enable early diagnosis and treatment. It involves longitudinal studies, biomarker analysis, and clinical assessments.